Navigation
banner

Scott Durum

Chief, Section of Cytokines and Immunity

NIH - National Cancer Center - Center for Cancer Research

 
Scott Durum

Scott Durum trained in immunology at Wake Forest, Oak Ridge, National Jewish and Yale before coming to the National Cancer Institute, National Institutes of Health. His lab has been interested in the IL-7 pathway for a number of years. Recently, together with collaborators, they found that this is a major pathway driving Acute Lymphoblastic Leukemia, the most common cancer in children. They are working to develop therapeutics directed against the IL-7 pathway in this disease.

Follow Scott Durum' at upcoming/ongoing conferences at gtcbio:

ImmunoTX Summit

ImmunoTX Summit